PhotonPharma Inc. Receives U.S. Patent for Innovative Cancer Immunotherapy

Patent Covers Novel Method for Producing Photosensitizer-Inactivated Cancer Cell with Enhanced Immunogenicity for use in Cancer Immunotherapy FORT COLLINS, Colo., Sept. 9, 2025 /PRNewswire/ — PhotonPharma, a biotechnology company developing next-generation cancer immunotherapies, today…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks